120 related articles for article (PubMed ID: 1829955)
1. Differential regulation of c-myc by progestins and antiestrogens in T-47D human breast cancer cells.
Wong MS; Murphy LC
J Steroid Biochem Mol Biol; 1991 Jul; 39(1):39-44. PubMed ID: 1829955
[TBL] [Abstract][Full Text] [Related]
2. Endogenous growth factor expression in T-47D, human breast cancer cells, associated with reduced sensitivity to antiproliferative effects of progestins and antiestrogens.
Murphy LC; Dotzlaw H
Cancer Res; 1989 Feb; 49(3):599-604. PubMed ID: 2783382
[TBL] [Abstract][Full Text] [Related]
3. Expression of insulin-like growth factor binding proteins by T-47D human breast cancer cells: regulation by progestins and antiestrogens.
Coutts A; Murphy LJ; Murphy LC
Breast Cancer Res Treat; 1994; 32(2):153-64. PubMed ID: 7532465
[TBL] [Abstract][Full Text] [Related]
4. Regulation of transforming growth factor alpha and transforming growth factor beta messenger ribonucleic acid abundance in T-47D, human breast cancer cells.
Murphy LC; Dotzlaw H
Mol Endocrinol; 1989 Apr; 3(4):611-7. PubMed ID: 2524651
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ
Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041
[TBL] [Abstract][Full Text] [Related]
6. C-myc overexpression, c-mil, c-myb expression in a breast tumor cell line. Effects of estrogen and antiestrogen.
Collyn-d'Hooghe M; Vandewalle B; Hornez L; Lantoine D; Revillion F; Lefebvre J; Kerckaert JP
Anticancer Res; 1991; 11(6):2175-9. PubMed ID: 1776859
[TBL] [Abstract][Full Text] [Related]
7. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
8. c-Myc overexpression and endocrine resistance in breast cancer.
McNeil CM; Sergio CM; Anderson LR; Inman CK; Eggleton SA; Murphy NC; Millar EK; Crea P; Kench JG; Alles MC; Gardiner-Garden M; Ormandy CJ; Butt AJ; Henshall SM; Musgrove EA; Sutherland RL
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):147-55. PubMed ID: 17052904
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of growth inhibition by antiestrogens and progestins in human breast and endometrial cancer cells.
Murphy LC; Dotzlaw H; Alkhalaf M; Coutts A; Miller T; Wong MS; Gong Y; Murphy LJ
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):117-21. PubMed ID: 1525052
[TBL] [Abstract][Full Text] [Related]
10. Regulation of gene expression in T-47D human breast cancer cells by progestins and antiprogestins.
Murphy LC; Alkhalaf M; Dotzlaw H; Coutts A; Haddad-Alkhalaf B
Hum Reprod; 1994 Jun; 9 Suppl 1():174-80. PubMed ID: 7962462
[TBL] [Abstract][Full Text] [Related]
11. Regulation of c-jun and jun-B by progestins in T-47D human breast cancer cells.
Alkhalaf M; Murphy LC
Mol Endocrinol; 1992 Oct; 6(10):1625-33. PubMed ID: 1448115
[TBL] [Abstract][Full Text] [Related]
12. C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells.
Venditti M; Iwasiow B; Orr FW; Shiu RP
Int J Cancer; 2002 May; 99(1):35-42. PubMed ID: 11948489
[TBL] [Abstract][Full Text] [Related]
13. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells].
Nomura Y; Tashiro H; Takaeko F
Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351
[TBL] [Abstract][Full Text] [Related]
14. Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells.
Kang Y; Cortina R; Perry RR
J Natl Cancer Inst; 1996 Mar; 88(5):279-84. PubMed ID: 8614006
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the growth-inhibitory effects of progestins and the antiestrogen hydroxyclomiphene on human breast cancer cells by epidermal growth factor and insulin.
Koga M; Musgrove EA; Sutherland RL
Cancer Res; 1989 Jan; 49(1):112-6. PubMed ID: 2642286
[TBL] [Abstract][Full Text] [Related]
16. [Cell cycle effects of antiestrogens and medroxyprogesterone acetate on the MCF-7 human breast cancer cell line].
Ikeda T; Enomoto K; Fujiwara K; Koh J; Ishii S; Fukutomi T; Nakamura A; Abe O; Tsuru S; Jinnaka H
Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2243-50. PubMed ID: 2937861
[No Abstract] [Full Text] [Related]
17. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
[TBL] [Abstract][Full Text] [Related]
18. Steroidal and nonsteroidal antiestrogens in breast cancer cells in culture.
Rochefort H; Bardon S; Chalbos D; Vignon F
J Steroid Biochem; 1984 Jan; 20(1):105-10. PubMed ID: 6368983
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of retinoids and antiestrogens on cell cycle progression and cell cycle regulatory genes in human breast cancer cells.
Wilcken NR; Sarcevic B; Musgrove EA; Sutherland RL
Cell Growth Differ; 1996 Jan; 7(1):65-74. PubMed ID: 8788034
[TBL] [Abstract][Full Text] [Related]
20. Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes.
Musgrove EA; Lee CS; Sutherland RL
Mol Cell Biol; 1991 Oct; 11(10):5032-43. PubMed ID: 1922031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
